#biotech

🏢Release 📈 Stocks

Flagship Pioneering Launches Etcelera to Scale AI-Driven Drug Discovery

October 29, 2026 (12 days ago)

Flagship Pioneering consolidates the technologies of Cellarity, Etiome, and Empress Therapeutics into a new AI-focused entity, Etcelera, appointing Ad Rawcliffe as CEO…

Etcelera Flagship Pioneering Cellarity +2

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

CLS and ClearPoint Neuro Join $3M NIH-Funded Spinal Metastases Research

October 29, 2026 (12 days ago)

CLS and ClearPoint Neuro partner with Dartmouth Health on a $2.98 million NIH-backed study to develop minimally invasive laser therapy for spinal…

CLS B CLPT

🌍 EUROPE Read More →

🏢Release 📈 Stocks

CLS and ClearPoint Neuro Join $3M NIH-Funded Spinal Metastases Research

October 29, 2026 (12 days ago)

CLS and ClearPoint Neuro partner with Dartmouth Health on a $2.98 million NIH-funded study to validate MR-guided laser therapy for spinal metastases.

CLS-B.ST CLPT

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Sobi Reports Positive Phase 3 Results for Gout Drug Candidate Pozdeutinurad

October 29, 2026 (12 days ago)

Sobi shares gain momentum as the company reports successful Phase 3 REDUCE-2 trial results, confirming the efficacy and safety of its investigational…

SOBI

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Jiangsu Hengrui Medicine Presents 64 Oncology Research Abstracts at ESMO 2026

October 29, 2026 (12 days ago)

Jiangsu Hengrui Pharmaceuticals highlights its global oncology R&D capabilities with 64 research abstracts presented at the 2026 ESMO congress in Madrid.

600276.SS

🌍 ASIA Read More →

🏢Release 🌐 Macro — 📊 Neutral

GHIT Fund Invests JPY 1.06 Billion to Accelerate Global Health R&D

October 29, 2026 (12 days ago)

The GHIT Fund allocates USD 6.8 million across nine international research initiatives to address persistent gaps in global health infrastructure and disease…

🌍 ASIA Read More →

🏢Release 📈 Stocks

HERVolution Validates IPT-001 Pipeline With HERV-K Expression Data

October 28, 2026 (12 days ago)

HERVolution shares gain momentum as new clinical data confirms HERV-K expression in 43 cancer types, validating the therapeutic potential of the company's…

HERVolution

🌍 EUROPE Read More →

🏢Release 📈 Stocks

TransCode Therapeutics Explores Strategic Alternatives for Lead Oncology Asset

October 28, 2026 (12 days ago)

Boston-based TransCode Therapeutics is seeking strategic partners or a potential sale for its lead oncology asset, TTX-MC138, currently in Phase 2a clinical…

RNA

🌍 AMERICAS Read More →

🏛️Filing 📈 Stocks

LENZ Therapeutics Discloses Restructuring Costs and Executive Departure

October 28, 2026 (12 days ago)

LENZ Therapeutics reports new operational costs and leadership changes in latest 8-K filing, marking a shift in corporate structure and financial strategy.

LENZ

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Danaher Subsidiary Genedata Launches New ELN Software for R&D Workflows

October 28, 2026 (12 days ago)

Danaher-owned Genedata introduces a new ELN solution to streamline R&D workflows and enhance AI readiness for biopharmaceutical research organizations.

DHR Genedata

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Transpharmation Acquires OrganoTherapeutics to Expand Neuroscience CRO Reach

October 28, 2026 (13 days ago)

Transpharmation Ltd. expands its global neuroscience CRO footprint through the strategic acquisition of OrganoTherapeutics, enhancing its preclinical research service offerings.

Transpharmation Ltd.

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Eli Lilly Licenses AI Speech Dataset to Advance Alzheimer's Research

October 28, 2026 (13 days ago)

Eli Lilly secures access to a specialized speech-analysis dataset from the ADDF, highlighting the growing role of artificial intelligence in identifying early-stage…

LLY

🌍 AMERICAS Read More →